1. Home
  2. CYPH vs XPL Comparison

CYPH vs XPL Comparison

Compare CYPH & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$1.22

Market Cap

73.4M

Sector

Health Care

ML Signal

N/A

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.83

Market Cap

74.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYPH
XPL
Founded
2011
1984
Country
United States
United States
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
73.4M
74.8M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CYPH
XPL
Price
$1.22
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.20
AVG Volume (30 Days)
4.0M
209.1K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.86
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.54
52 Week High
$3.70
$0.98

Technical Indicators

Market Signals
Indicator
CYPH
XPL
Relative Strength Index (RSI) 58.21 44.38
Support Level $0.88 $0.68
Resistance Level $1.30 $0.88
Average True Range (ATR) 0.15 0.04
MACD 0.01 -0.01
Stochastic Oscillator 55.34 13.77

Price Performance

Historical Comparison
CYPH
XPL

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

Share on Social Networks: